# A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis

> **NCT04985812** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 44 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** JNJ-67484703
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04985812
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-18
- **Primary completion:** 2023-05-18
- **Final completion:** 2023-05-18
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04985812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04985812, "A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04985812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*